Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies

Area of Science:

• Immunology
• Hepatology
• Virology

Background:

• Acute hepatitis B virus (HBV) infection is typically resolved by immune responses, but a subset of individuals develop chronic infections.
• Chronic HBV carriers often exhibit dysfunctional or exhausted HBV-specific T cells, hindering viral clearance.
• Current treatments like IFN-α and antiviral drugs offer limited durable immunological control.

Purpose of the Study:

• To review recent findings on HBV immunopathology and model systems.
• To discuss current therapeutic strategies for chronic HBV infection.
• To explore novel approaches for eliminating HBV-infected hepatocytes.

Main Methods:

• Review of existing literature on HBV immunology and treatment.
• Analysis of HBV immunopathology and dysfunction of T cells.
• Discussion of adoptive T-cell transfer as a potential therapy.

Main Results:

• HBV-specific T-cell responses are critical for controlling infection and liver damage.
• Chronic HBV patients frequently display deleted, dysfunctional, or exhausted HBV-specific T cells.
• Existing therapies have limited success in restoring durable T-cell immunity.

Conclusions:

• Eliminating persistently infected hepatocytes remains a significant challenge in chronic HBV.
• Adoptive T-cell transfer targeting HBV antigen+ cells is a promising strategy for eliminating residual cccDNA.
• Further research into HBV immunopathology and novel immunotherapies is needed.